Related Experiment Video
Updated: Jun 23, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Cooperation between molecular targets of costimulation in promoting T cell persistence and tumor regression
Baohua Zhao1, Aihua Song, Rizwanul Haque
1Department of Microbiology and Immunology and Pennsylvania State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Abstract:
Costimulation regulates multiple cellular processes of T cells inducing proliferation, expansion, and survival. The molecular targets of costimulation might then be useful to augment T cell activities. Two defined targets of costimulatory signals in primary T cells are the anti-apoptotic bcl-2 family molecule Bcl-x(L), and survivin, an inhibitor of apoptosis family member that might regulate both cell division and survival. However, the relative importance of, and relationship between, these molecules in primary T cells is not clear. To understand whether they have overlapping or cooperative functions, we used retrovirus-mediated transduction to introduce Bcl-x(L) and survivin separately, or together linked by a 2A picornavirus self-cleaving peptide, into Ag-responding CD8(+) T cells. We found that CD8(+) effector T cells expressing both Bcl-x(L) and survivin strongly expanded at an early stage and had a long-term survival advantage over cells transduced with either molecule alone. In vivo, with response to tumor-expressed Ag following adoptive T cell transfer, Ag-reactive CD8(+) T cells expressing both Bcl-x(L) and survivin displayed greatly enhanced tumor protective activity compared with CD8(+) T cells expressing either molecule introduced separately. These results indicate that Bcl-x(L) and survivin can critically contribute in a cooperative, nonredundant manner to augment the accumulation and persistence of CD8(+) T cells following encounter with Ag. The data provide new insights into why costimulatory signals might need to be sustained over time and suggest a potential novel approach to augment cellular immunotherapy for cancer.
Insights
Combining Bcl-x(L) and survivin enhances CD8(+) T cell expansion and survival, boosting anti-tumor activity. These findings suggest a novel strategy for augmenting cellular immunotherapy in cancer treatment.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Costimulation is crucial for T cell proliferation, expansion, and survival.
- Bcl-x(L) and survivin are key anti-apoptotic molecules targeted by costimulatory signals in T cells.
- The precise relationship and cooperative functions of Bcl-x(L) and survivin in primary T cells remain unclear.
Purpose of the Study:
- To investigate the cooperative or overlapping functions of Bcl-x(L) and survivin in CD8(+) T cells.
- To determine the impact of co-expressing Bcl-x(L) and survivin on T cell accumulation, persistence, and anti-tumor activity.
Main Methods:
- Retrovirus-mediated transduction was used to introduce Bcl-x(L) and survivin into Ag-responding CD8(+) T cells.
- Cells were engineered to express Bcl-x(L) and survivin separately or together.
- In vivo studies involved adoptive T cell transfer into tumor-bearing models to assess anti-tumor efficacy.
Main Results:
- Co-expression of Bcl-x(L) and survivin led to significantly enhanced early-stage expansion of CD8(+) effector T cells.
- T cells expressing both molecules exhibited a prolonged survival advantage compared to those expressing either alone.
- In vivo, CD8(+) T cells expressing both Bcl-x(L) and survivin demonstrated superior tumor protective activity.
Conclusions:
- Bcl-x(L) and survivin cooperate in a nonredundant manner to enhance CD8(+) T cell accumulation and persistence post-antigen encounter.
- Sustained costimulatory signals may be necessary to maintain the synergistic effects of Bcl-x(L) and survivin.
- This study proposes a novel approach to enhance cellular immunotherapy for cancer by augmenting T cell function.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

